Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Sep 15;98(6):1381–1388. doi: 10.1172/JCI118925

Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing.

D C Rockey 1, J J Chung 1
PMCID: PMC507564  PMID: 8823303

Abstract

The liver's response to chronic injury is fibrosis, which is analogous to wound healing in other organs. Hepatic wounding is characterized by the "activation" of resident stellate cells (lipocytes, Ito cells) to myofibroblast-like cells that produce increased amounts of smooth muscle alpha-actin and extracellular matrix. Stellate cells possess abundant endothelin (ET) receptors (ETA/B) and, therefore, are subject to the effects of ET-1 and 3. In this study, we investigated whether ETs contribute to the activation of stellate cells and consequently, fibrogenesis. In cultured stellate cells, ET-1 and sarafotoxin S6C (a potent ETB receptor agonist) stimulated stellate cell activation, as assessed by expression of smooth muscle alpha-actin. Furthermore, the mixed ETA/B receptor antagonist, bosentan, blocked this process. Next, we administered bosentan during the induction of liver injury in two mechanistically distinct forms of hepatic wounding. Bosentan reduced levels of type I collagen and cellular fibronectin mRNAs in whole-liver tissue extracts in both models. In freshly isolated stellate cells from injured livers, bosentan reduced expression of activation markers, including smooth muscle alpha-actin and extracellular matrix mRNAs. We further demonstrate that endothelin antagonism after establishment of fibrosing injury reduced stellate cell activation and matrix production. These data indicate that ET contributes to stellate cell activation and fibrogenesis. Because ET is upregulated in diverse forms of parenchymal injury, we speculate that ET may play an important role in the wound-healing response.

Full Text

The Full Text of this article is available as a PDF (280.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appleton I., Tomlinson A., Chander C. L., Willoughby D. A. Effect of endothelin-1 on croton oil-induced granulation tissue in the rat. A pharmacologic and immunohistochemical study. Lab Invest. 1992 Dec;67(6):703–710. [PubMed] [Google Scholar]
  2. Battistini B., Chailler P., D'Orléans-Juste P., Brière N., Sirois P. Growth regulatory properties of endothelins. Peptides. 1993 Mar-Apr;14(2):385–399. doi: 10.1016/0196-9781(93)90057-n. [DOI] [PubMed] [Google Scholar]
  3. Baynash A. G., Hosoda K., Giaid A., Richardson J. A., Emoto N., Hammer R. E., Yanagisawa M. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell. 1994 Dec 30;79(7):1277–1285. doi: 10.1016/0092-8674(94)90018-3. [DOI] [PubMed] [Google Scholar]
  4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  5. Clozel M., Breu V., Gray G. A., Kalina B., Löffler B. M., Burri K., Cassal J. M., Hirth G., Müller M., Neidhart W. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther. 1994 Jul;270(1):228–235. [PubMed] [Google Scholar]
  6. Friedman S. L., Roll F. J., Boyles J., Arenson D. M., Bissell D. M. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem. 1989 Jun 25;264(18):10756–10762. [PubMed] [Google Scholar]
  7. Friedman S. L. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 1993 Jun 24;328(25):1828–1835. doi: 10.1056/NEJM199306243282508. [DOI] [PubMed] [Google Scholar]
  8. Fujitani Y., Ninomiya H., Okada T., Urade Y., Masaki T. Suppression of endothelin-1-induced mitogenic responses of human aortic smooth muscle cells by interleukin-1 beta. J Clin Invest. 1995 Jun;95(6):2474–2482. doi: 10.1172/JCI117948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gabbiani G., Ryan G. B., Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia. 1971 May 15;27(5):549–550. doi: 10.1007/BF02147594. [DOI] [PubMed] [Google Scholar]
  10. Gandhi C. R., Behal R. H., Harvey S. A., Nouchi T. A., Olson M. S. Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes. Biochem J. 1992 Nov 1;287(Pt 3):897–904. doi: 10.1042/bj2870897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gandhi C. R., Stephenson K., Olson M. S. Endothelin, a potent peptide agonist in the liver. J Biol Chem. 1990 Oct 15;265(29):17432–17435. [PubMed] [Google Scholar]
  12. Giaid A., Michel R. P., Stewart D. J., Sheppard M., Corrin B., Hamid Q. Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet. 1993 Jun 19;341(8860):1550–1554. doi: 10.1016/0140-6736(93)90694-c. [DOI] [PubMed] [Google Scholar]
  13. Giaid A., Saleh D., Yanagisawa M., Forbes R. D. Endothelin-1 immunoreactivity and mRNA in the transplanted human heart. Transplantation. 1995 May 15;59(9):1308–1313. [PubMed] [Google Scholar]
  14. Goto K., Warner T. D. Molecular pharmacology. Endothelin versatility. Nature. 1995 Jun 15;375(6532):539–540. doi: 10.1038/375539a0. [DOI] [PubMed] [Google Scholar]
  15. Housset C., Rockey D. C., Bissell D. M. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9266–9270. doi: 10.1073/pnas.90.20.9266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jaffer F. E., Knauss T. C., Poptic E., Abboud H. E. Endothelin stimulates PDGF secretion in cultured human mesangial cells. Kidney Int. 1990 Dec;38(6):1193–1198. doi: 10.1038/ki.1990.333. [DOI] [PubMed] [Google Scholar]
  17. Jarnagin W. R., Rockey D. C., Koteliansky V. E., Wang S. S., Bissell D. M. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol. 1994 Dec;127(6 Pt 2):2037–2048. doi: 10.1083/jcb.127.6.2037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jouneaux C., Mallat A., Serradeil-Le Gal C., Goldsmith P., Hanoune J., Lotersztajn S. Coupling of endothelin B receptors to the calcium pump and phospholipase C via Gs and Gq in rat liver. J Biol Chem. 1994 Jan 21;269(3):1845–1851. [PubMed] [Google Scholar]
  19. Katwa L. C., Guarda E., Weber K. T. Endothelin receptors in cultured adult rat cardiac fibroblasts. Cardiovasc Res. 1993 Dec;27(12):2125–2129. doi: 10.1093/cvr/27.12.2125. [DOI] [PubMed] [Google Scholar]
  20. Kountouras J., Billing B. H., Scheuer P. J. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 1984 Jun;65(3):305–311. [PMC free article] [PubMed] [Google Scholar]
  21. Kuhn C., McDonald J. A. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol. 1991 May;138(5):1257–1265. [PMC free article] [PubMed] [Google Scholar]
  22. Leivas A., Jiménez W., Lamas S., Bosch-Marcé M., Oriola J., Clària J., Arroyo V., Rivera F., Rodés J. Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites. Gastroenterology. 1995 Jun;108(6):1842–1848. doi: 10.1016/0016-5085(95)90148-5. [DOI] [PubMed] [Google Scholar]
  23. Lüscher T. F. Endothelin. J Cardiovasc Pharmacol. 1991;18 (Suppl 10):S15–S22. [PubMed] [Google Scholar]
  24. Maher J. J., McGuire R. F. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest. 1990 Nov;86(5):1641–1648. doi: 10.1172/JCI114886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Malkusch W., Rehn B., Bruch J. Advantages of Sirius Red staining for quantitative morphometric collagen measurements in lungs. Exp Lung Res. 1995 Jan-Feb;21(1):67–77. doi: 10.3109/01902149509031745. [DOI] [PubMed] [Google Scholar]
  26. Mallat A., Fouassier L., Préaux A. M., Gal C. S., Raufaste D., Rosenbaum J., Dhumeaux D., Jouneaux C., Mavier P., Lotersztajn S. Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. J Clin Invest. 1995 Jul;96(1):42–49. doi: 10.1172/JCI118052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Matsuoka M., Pham N. T., Tsukamoto H. Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver. 1989 Apr;9(2):71–78. doi: 10.1111/j.1600-0676.1989.tb00382.x. [DOI] [PubMed] [Google Scholar]
  28. Melton D. A., Krieg P. A., Rebagliati M. R., Maniatis T., Zinn K., Green M. R. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 1984 Sep 25;12(18):7035–7056. doi: 10.1093/nar/12.18.7035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Moore K., Wendon J., Frazer M., Karani J., Williams R., Badr K. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med. 1992 Dec 17;327(25):1774–1778. doi: 10.1056/NEJM199212173272502. [DOI] [PubMed] [Google Scholar]
  30. Nakatsukasa H., Nagy P., Evarts R. P., Hsia C. C., Marsden E., Thorgeirsson S. S. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest. 1990 Jun;85(6):1833–1843. doi: 10.1172/JCI114643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ohlstein E. H., Nambi P., Douglas S. A., Edwards R. M., Gellai M., Lago A., Leber J. D., Cousins R. D., Gao A., Frazee J. S. SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8052–8056. doi: 10.1073/pnas.91.17.8052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rockey D. C., Boyles J. K., Gabbiani G., Friedman S. L. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol. 1992 Apr;24(2):193–203. [PubMed] [Google Scholar]
  33. Rockey D. C. Characterization of endothelin receptors mediating rat hepatic stellate cell contraction. Biochem Biophys Res Commun. 1995 Feb 15;207(2):725–731. doi: 10.1006/bbrc.1995.1247. [DOI] [PubMed] [Google Scholar]
  34. Rockey D. C., Housset C. N., Friedman S. L. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest. 1993 Oct;92(4):1795–1804. doi: 10.1172/JCI116769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Saperstein L. A., Jirtle R. L., Farouk M., Thompson H. J., Chung K. S., Meyers W. C. Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology. 1994 Feb;19(2):412–417. [PubMed] [Google Scholar]
  36. Sappino A. P., Schürch W., Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest. 1990 Aug;63(2):144–161. [PubMed] [Google Scholar]
  37. Simonson M. S., Herman W. H. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. Cross-talk between G protein-coupled receptors and pp60c-src. J Biol Chem. 1993 May 5;268(13):9347–9357. [PubMed] [Google Scholar]
  38. Stephenson K., Harvey S. A., Mustafa S. B., Eakes A. T., Olson M. S. Endothelin association with the cultured rat Kupffer cell: characterization and regulation. Hepatology. 1995 Sep;22(3):896–905. [PubMed] [Google Scholar]
  39. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  40. de Leeuw A. M., McCarthy S. P., Geerts A., Knook D. L. Purified rat liver fat-storing cells in culture divide and contain collagen. Hepatology. 1984 May-Jun;4(3):392–403. doi: 10.1002/hep.1840040307. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES